Weak Q2 expected from Lupin
  • WebDesk BTVI
  • Oct 31 2018

Lower other income and higher interest expense to weigh on profitability says Amey Chalke,Pharma analyst , HDFC Securities while talking about a preview of Lupin’s Q2.